ArticleRSC advances2021
Optimized energetic HNTO/AN co-crystal and its thermal decomposition kinetics in the presence of energetic coordination nanomaterials based on functionalized graphene oxide and cobalt.
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Molecular dynamics simulation of TNT/ATL cocrystal morphology under different conditions.Journal of molecular modeling · 2026Article
- Properties of Mixed Crystal Coprecipitation Substances of Ammonium Nitrate and Potassium Perchlorate Prepared by the Evaporative Solvent Method.ACS omega · 2024Article
- Development and Characterization of New Energetic Composites Based on HNTO/AN Co-Crystal and Nitro-Cellulosic Materials.Polymers · 2023Article
- Elaboration, Characterization and Thermal Decomposition Kinetics of New Nanoenergetic Composite Based on Hydrazine 3-Nitro-1,2,4-triazol-5-one and Nanostructured Cellulose Nitrate.Molecules (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present research aims to select the optimal molar ratio of hydrazine 3-nitro-1,2,4-triazol-5-one (HNTO) and ammonium nitrate (AN) to produce an energetic co-crystal. For a comparison purpose, the heat release, cost, density and hygroscopicity of the different co-crystals were evaluated. The obtained results indicated that HNTO/AN at the 1 : 3 ratio exhibited a higher heat release, better thermal stability, low water content and a reasonable cost, compared to other co-crystals. This new co-crystal was fully characterized through powder X-ray diffraction (XRD), infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC), confirming that this latter displayed similar characteristics to those of the co-crystal with a 1 : 1 ratio, which was recently developed. On the other hand, the catalytic activity of two energetic coordination polymers of triaminoguanidine-cobalt (T-Co) complexes, with or without graphene oxide (GO-T-Co-T), on the thermolysis of the developed co-crystal has been also assessed by DSC under non-isothermal conditions. It is revealed that these catalysts have greatly decreased the decomposition temperature of the HNTO/AN cocrystal. Moreover, because of the complete decomposition in the case of the (HNTO/AN)/GO-T-Co-T composite, the heat release has been increased as well. Isoconversional integral kinetic methods were exploited to determine the kinetic parameters of the different systems. According to the obtained results, these catalysts have a strong catalytic action on the decomposition of the co-crystal AN/HNTO for which the activation energy and the pre-exponential factor are considerably lowered. Consequently, the developed co-crystal and the energetic catalysts could be considered as potential ingredients for the next generation of composite solid propellant formulations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.